文献速递神经眼科眼外伤眼整形与眼眶

导航引导经泪阜眶入路视神经管减压术治疗间接性外伤性视神经病变的长期疗效

Navigation-guided transcaruncular orbital optic canal decompression in indirect traumatic optic neuropathy: long-term outcomes.
PubMed 文献 · Br J Ophthalmol · 2024-05-21

前瞻性观察研究纳入52例对激素治疗无反应的间接性外伤性视神经病变患者,分为有视神经管骨折行导航引导经泪阜眶视神经管减压术组、无骨折行该手术组及拒绝手术的未减压组。结果显示两手术组视力及视觉诱发电位均有改善,且均优于未减压组;初诊视力和DeLano 1型视神经管为显著预后因素。

要点

  • 导航引导经泪阜眶视神经管减压术可在直视下从眶最前端处理视神经管。
  • 有或无视神经管骨折患者术后视力及VEP均有改善,且优于未减压组。
  • 初诊视力和DeLano 1型视神经管是显著的预后因素。

核心结论

  • 导航引导经泪阜眶视神经管减压术是一种微创经泪阜路径到达视神经管的方法,使眼科医生能够在直视下从眶最前端进行减压。
  • 对有或无视神经管骨折且对激素治疗无反应的间接性外伤性视神经病变患者,采用该手术后显示出可比且更优的结局。

研究设计与样本

  • 前瞻性观察性研究,连续纳入52例对激素治疗无反应的间接性外伤性视神经病变患者。
  • 分为三组:I组为有视神经管骨折行导航引导经泪阜眶视神经管减压术者,II组为无视神经管骨折行该手术者,III组为选择不接受该手术的未减压组。
  • 主要结局为术后1周、3个月和1年的视力改善,次要结局为1年时视觉诱发电位的振幅和潜伏期。

主要发现

  • I组平均视力从初诊2.55±0.67 LogMAR改善至末次随访2.03±0.96 LogMAR(p<0.001)。
  • II组平均视力从初诊2.62±0.56 LogMAR改善至末次随访2.33±0.72 LogMAR(p=0.01)。
  • I组和II组视觉诱发电位振幅均观察到统计学显著改善(p<0.01),II组视觉诱发电位潜伏期亦显著改善(p<0.01)。
  • I组和II组患者结局均优于未减压组患者。
  • 初诊视力和DeLano 1型视神经管被观察为显著预后因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the surgical outcomes using navigation-guided transcaruncular orbital optic canal decompression (NGTcOCD) and investigate the relationship between visual prognosis. visual evoked potential (VEP), association with DeLano type of optic canal and Onodi cells in patients with indirect traumatic optic neuropathy (TON). DESIGN: Prospective observational. METHODS: Fifty-two consecutive patients with indirect TON unresponsive to steroid therapy were divided into three groups where Group I comprised of cases with optic canal fracture who underwent NGTcOCD, Group II without optic canal fracture who underwent NGTcOCD and Group III, no-decompression group who chose not to undergo NGTcOCD. An improvement in visual acuity (VA) at 1 week, 3 months and 1 year and amplitude and latency of VEP at 1 year were considered as primary and secondary outcomes, respectively. RESULTS: The mean VA improved from 2.55±0.67 and 2.62±0.56 LogMAR at presentation to 2.03±0.96 and 2.33±0.72 LogMAR at final follow-up among Group I and Group II patients, respectively (p<0.001 and p=0.01). Statistically significant improvement observed among both the Groups in VEP amplitude (p=<0.01) and among Group II in VEP latency (p<0.01). Both Group I and Group II patients have better outcomes than patients in no-decompression group. VA at presentation and Type 1 DeLano optic canal were observed as significant prognostic factors. CONCLUSIONS: NGTcOCD serves as a minimally invasive transcaruncular route to the optic canal which enables ophthalmologists to perform decompression from the anterior-most orbital end under direct visualisation. Patients with indirect TON with or without optic canal fracture and unresponsive to steroid therapy when managed with NGTcOCD have shown comparable and superior outcomes.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bhattacharjee K, Soni D, Venkatraman V, et al. Navigation-guided transcaruncular orbital optic canal decompression in indirect traumatic optic neuropathy: long-term outcomes. Br J Ophthalmol. 2024. PMID: 37414533. doi:10.1136/bjo-2023-323282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。